Skip to main content

Obesity Management Market Share, Size, Global Opportunity, Technology and Applications

Obesity Management Market for weight loss and diet Insights 2019 by Type [Medication (Orlistat, Lorcaserin, Phentermine and Topiramate, Bupropion and Naltrexone and Liraglutide) and Surgery (Laparoscopic Adjustable Gastric Band, Gastric Sleeve and Gastric Bypass)] and Regional Analysis, size, Share, Technology, Growth Trends  and Forecast To 2025.
The “Obesity Management Market size is expected to register 8.4% CAGR, expected to be valued at USD 9.34 Billion in 2025.”, states the latest Market Research Future (MRFR) report.
Obesity Management Market Overview
Obesity is a chronic condition that is characterized by excessive storage and accumulation of fats in the body. It is measured by the body mass index (BMI). Obesity, along with affecting the appearance of a person also results in chronic diseases. Obesity management includes therapies, products, and services that help in reducing and managing weight in those suffering from obesity.
Key Players 
Key players have used different strategies to create a niche in the market
such as mergers and acquisitions, expansions, partnerships and more. These are the Notable players profiled in the obesity management market report:
  • Pfizer Inc. (US)
  • and Merck Sharp & Dohme Corp.
  • subsidiary of Merck & Co. Inc. (US)
  • GlaxoSmithKline Plc. (UK)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Herbalife Ltd. (US)
  • Apollo Endosurgery (US)
  • AstraZeneca (UK)
  • Ethicon Inc. (US)
  • and Others.
Obesity Management Market Segmentation
The Market Research Future report provides an all-inclusive segmental analysis of the obesity management market on the basis of lifestyle changes, surgery, and prescription.
  • the obesity management market is segmented By prescription,
    • liraglutide (Saxenda)
    • bupropion and naltrexone (Contrave)
    • phentermine and topiramate (Qsymia)
    • lorcaserin (Belvig)
    • orlistat (Xenical)
    • and others.
  • the obesity management market is segmented By surgery,
    • biliopancreatic diversion with dietary switch
    • laparoscopic adjustable gastric banding
    • gastric bypass surgery
    • and Others
  • the obesity management market is segmented By lifestyle changes,
    • exercise
    • dietary changes
    • and others.
Access the Premium Research Details along with Complete TOC@ https://www.marketresearchfuture.com/reports/obesity-management-market-2690
Industry News 
October 2019: International and local, regional faculty of multi-disciplinary experts recently gathered in Abu Dhabi for the 2019 UAE Obesity Conference for discussing and sharing latest trends in obesity management and treatment under the theme titled “It’s time to act upon obesity.” There were presentations for raising obesity pandemic awareness and its associated diseases. Participants analyzed obesity challenges, childhood obesity, and surgical and medical management of obesity.  
LIST OF FIGURES
FIGURE 1 RESEARCH PROCES
FIGURE 2 MARKET STRUCTURE OF THE GLOBAL OBESITY MANAGEMENT MARKET
FIGURE 3 MARKET DYNAMICS OF THE GLOBAL OBESITY MANAGEMENT MARKET
FIGURE 4 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY TYPE, 2018 (%)
FIGURE 5 GLOBAL OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 7 AMERICAS: OBESITY MANAGEMENT MARKET SHARE BY REGION, 2018 (%)
FIGURE 6 NORTH AMERICA: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 7 EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 8 WESTERN EUROPE: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 9 ASIA-PACIFIC: OBESITY MANAGEMENT MARKET SHARE, BY COUNTRY, 2018 (%)
Continued…
By region, the obesity management market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...
3 comments
Read more

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...
Post a Comment
Read more

North America wheelchair transportation Market by Leading Key Players, Product Applications in that Regional Forecast 2028

  North America Active Wheelchair Market Overview: The North America Active Wheelchair Market size is expected to grow at more than 7.7% CAGR to reach above USD 970 million by 2028 from a little above USD 502 million in 2019. Explore 27 market data Tables spread through nearly 57 Pages and in-depth analysis on “North AmericaActive Wheelchair market By Type (Manual, Powered), Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury) and by Country (US, Canada, Mexico), Regional Trends and Forecast from 2019 to 2028. Global North America active  wheelchair transportation   Market research provides a detailed Analytical Insights of global Market size, regional and country-level scope, segmentation wise growth, global share, Competition Scenario, sales analysis, impact global Market players on domestic players, value chain optimization, tra...
Post a Comment
Read more